pyrazolanthrone has been researched along with angiotensin i in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ai, Y; Liu, Z; Ma, X; Ming, G; Xu, D; Zhang, L; Zhao, S | 1 |
| Chen, J; Cheng, F; Feng, J; Lan, J; Lei, Y; Mei, W; Xu, Q; Zeng, B; Zhai, Y; Zhang, W; Zhen, Y; Zheng, D | 1 |
2 other study(ies) available for pyrazolanthrone and angiotensin i
| Article | Year |
|---|---|
Angiotensin-(1-7)/Mas Signaling Inhibits Lipopolysaccharide-Induced ADAM17 Shedding Activity and Apoptosis in Alveolar Epithelial Cells.
Topics: ADAM Proteins; ADAM17 Protein; Angiotensin I; Anthracenes; Apoptosis; Epithelial Cells; Humans; Lipopolysaccharides; MAP Kinase Kinase 4; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pulmonary Alveoli; Receptors, G-Protein-Coupled; RNA, Small Interfering; Signal Transduction; Transfection | 2016 |
Angiotensin-(1-7) protects cardiomyocytes against high glucose-induced injuries through inhibiting reactive oxygen species-activated leptin-p38 mitogen-activated protein kinase/extracellular signal-regulated protein kinase 1/2 pathways, but not the leptin
Topics: Acetylcysteine; Angiotensin I; Animals; Anthracenes; Apoptosis; Cell Line; Glucose; Imidazoles; Leptin; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Myocytes, Cardiac; Peptide Fragments; Pyridines; Rats; Reactive Oxygen Species | 2017 |